drug

Deadly anemia drugs like Procrit made billions - FDA kept their dangers a secret to protect pharma profits

Monday, August 06, 2012 by: J. D. Heyes
Tags: anemia drugs, dangers, profits

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
Biologist explains how marijuana causes tumor cells to commit suicide
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
Companies begin planting microchips under employees' skin
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
Chemotherapy kills cancer patients faster than no treatment at all
Why flu shots are the greatest medical fraud in history
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
Flu vaccine kills 13 in Italy; death toll rises
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Whooping cough outbreak at Massachusetts high school affected only vaccinated students

Delicious
(NaturalNews) The agencies and bureaucracies of our Leviathan government were created for our own good, we are constantly told, which is also the excuse we're given anytime a group of lawmakers or citizens calls for any of them to be dismantled.

That excuse may no longer hold water for the Food and Drug Administration which, according to a recent Washington Post report, could have some liability in covering for a drug that a growing body of research says is dangerous and deadly.

For many years, the report said, three drugs known as Epogen, Procrit and Aranesp were among the top-selling prescription drugs in the U.S., raking in more than $8 billion annually for a pair of Big Pharma corporations - Amgen and Johnson & Johnson. In fact, these two companies were stars among stars; for a number of years, Epogen was the single costliest medicine under Medicare, costing U.S. taxpayers as much as $3 billion a year.

"The trouble, as a growing body of research has shown, is that for about two decades, the benefits of the drug - including 'life satisfaction and happiness' according to the FDA-approved label - were wildly overstated, and potentially lethal side effects, such as cancer and strokes, were overlooked," the Washington Post reported.

Shocking, to say the least, but there's more.

Medicare researches last year said, in an 84-page study, that they found among most kidney patients - the original and largest market for the trio of drugs - no solid evidence the medications made anyone feel better, improved their chances of survival or even had any "clinical benefit" outside of elevating one statistic for red blood cell count.

So while the drug companies had made tens of billions in profits over more than two decades, much of it from unsuspecting taxpayers, millions of patients were given dangerous doses of the medications to no advantage.

How?

Economic incentives, willing participants, congressional liability

"To answer the question, The Washington Post obtained the agreements between the drug makers and the Food and Drug Administration, reviewed thousands of pages of transcripts and company reports, and relied on new academic research, some by doctors who once administered the drugs but now look askance at the drug makers' original claims," the paper reported.

The paper said part of the blame comes from economic incentives built into the U.S. healthcare system, which can lead to inefficiencies and potentially deadly uses for drugs. But there is more here than simply that.

Drug makers cannot and will not manufacture and market drugs at a loss, that much is a given. But the FDA, according to the Post's report, shares as much blame as anyone for this travesty. So, too, does Congress.

The paper said Amgen launched a well-funded research and lobbying campaign that was ultimately successful to win "far-reaching approvals" from the FDA. But both companies held drug trials that obviously missed (or ignored) the dangers while touting benefits that, 22 years later, would be disclosed as unfounded.

They also took more than 10 years to fulfill research commitments to the FDA, which - finally - moved to reign in the largest doses of the drugs. The agency was then stifled in its efforts by a "high-powered lobbying effort" aimed at Congress until lawmakers forced regulators to back off.

'It was just easy to do'

Sound familiar?

The paper also points an accusing finger at doctors and hospitals.

"Americans might like to think that doctors focus on only their health. But physicians and hospitals have to pay the bills, too, and, in some cases, the more they treat a patient, the more they earn. This was especially true in the case of the anemia drugs: The bigger the dose, the more they made," said the Post.

Incentives offered to them by the drug makers to increase doses ultimately worked. By 2007, some 80 percent of 175,000 dialysis patients on Medicare were being given the drugs at levels above what the FDA believes now is safe.

"It was just so easy to do - you put this stuff in the patient's arm, and you made thousands of dollars," Charles Bennett, endowed chair at the Medication Safety and Efficacy Center of Economic Excellence at the University of South Carolina and a critic of the use of the drugs in cancer patients, told the paper. "An oncologist could make anywhere from $100,000 to $300,000 a year from this alone. And all the while they were told that it was good for the patient."

Sources:

http://www.washingtonpost.com

http://www.naturalnews.com/023852_patients_drugs_drug.html

http://www.naturalnews.com/Big_Pharma.html

http://www.drugs.com/stats/procrit

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.